Cadazolid
- Generic Name
- Cadazolid
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C29H29F2N3O8
- CAS Number
- 1025097-10-2
- Unique Ingredient Identifier
- 2OEA2UN10Y
- Background
Cadazolid has been used in trials studying the treatment of Clostridium Difficile Infection.
- Associated Conditions
- -
- Associated Therapies
- -
Comparison of Cadazolid Versus Vancomycin in Children With Clostridium Difficile-associated Diarrhea (CDAD)
- Conditions
- Interventions
- First Posted Date
- 2017-04-10
- Last Posted Date
- 2019-04-03
- Lead Sponsor
- Actelion
- Target Recruit Count
- 1
- Registration Number
- NCT03105479
- Locations
- ๐บ๐ธ
University of Chicago, Dept. Of Medicine, Chicago, Illinois, United States
๐บ๐ธSUNY Upstate Medical University - Upstate Golisano Children's Hospital (GCH) - Pediatric Designated AIDS Center, Syracuse, Ohio, United States
๐ช๐ธHospital Sant Joan de Dรฉu, Esplugues, Barcelona, Spain
Study to Investigate the Pharmacokinetics and Safety of Cadazolid in Patients With Clostridium Difficile Infection
- First Posted Date
- 2014-02-03
- Last Posted Date
- 2014-02-03
- Lead Sponsor
- Actelion
- Target Recruit Count
- 6
- Registration Number
- NCT02053181
- Locations
- ๐ญ๐ท
Clinical Hospital for Infective Disease, Zagreb, Croatia
Efficacy and Safety of Cadazolid Versus Vancomycin in Subjects With Clostridium Difficile - Associated Diarrhea
- Conditions
- Interventions
- First Posted Date
- 2013-11-20
- Last Posted Date
- 2018-05-04
- Lead Sponsor
- Actelion
- Target Recruit Count
- 632
- Registration Number
- NCT01987895
- Locations
- ๐ช๐ธ
Investigator Site, Majadahonda, Spain
Efficacy and Safety of Cadazolid Versus Vancomycin in Subjects With Clostridium Difficile-associated Diarrhea
- Conditions
- Interventions
- First Posted Date
- 2013-11-14
- Last Posted Date
- 2018-05-24
- Lead Sponsor
- Actelion
- Target Recruit Count
- 631
- Registration Number
- NCT01983683
- Locations
- ๐ญ๐ท
Investigator Site 2784, Zagreb, Croatia
๐ญ๐ทInvestigator Site 2786, Zagreb, Croatia
๐ญ๐ทInvestigator Site 2780, Zagreb, Croatia
Efficacy, Safety and Tolerability of Cadazolid in Subjects With Clostridium Difficile Associated Diarrhea (CDAD)
- Conditions
- Interventions
- First Posted Date
- 2010-10-18
- Last Posted Date
- 2017-06-14
- Lead Sponsor
- Actelion
- Target Recruit Count
- 84
- Registration Number
- NCT01222702
- Locations
- ๐จ๐ฆ
Clinical Investigative Site 6601, Montreal, Quebec, Canada
๐บ๐ธClinical Investigative Site 6935, Marietta, Georgia, United States
๐ธ๐ชClinical Investigative Site 6702, Orebro, Sweden
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.